1BP-LSD Starter Kit
Shipping
Standard (shipping within 2 business days after receipt of payment) – free shipping on orders over €69
Safety Instructions
Important Information
This is a research chemical and is therefore not for human consumption! Further information can be found in the description.
Pickup available at Shop location
Usually ready in 24 hours
Product description
Buy 1BP-LSD Starter Research Kit:
The 1BP-LSD Starter Kit is a compact, versatile solution for research projects aiming to systematically investigate or compare different dosage ranges. Instead of limiting itself to a single format, the kit offers broad methodological scope within a unified research concept.
1BP-LSD is a structurally modified lysergamide derivative that is currently not covered by common narcotics or NpSG regulations, and is therefore used as a research chemical. By combining several standardized units, the Starter Kit is particularly suitable for:
- quantitative comparative studies
- reference and archive analyses
- methodological basic research
- reproducible experimental series with clearly defined stages
Product: 1BP-LSD Starter Research Kit
Included Units:
- 3× green pellets with 10 μg 1BP-LSD ("Microdose")
- 2× blotters with 175 μg 1BP-LSD ("Macrodose")
- 1× orange pellet with 250 μg 1BP-LSD ("Megadose")
Active Ingredient: 1BP-LSD L-Tartrate
Other Ingredients:
- Pellets: Colorant, MCC102, Silicon Dioxide, Magnesium Stearate, Di-Calcium Phosphate
- Blotters: Soy-based ink, Blotting paper
Molecular Mass: 609.37 g·mol⁻¹
Chemical Formula: C₃₇H₄₈BN₃O₄
Empirical Formula: C37H48BN3O4
IUPAC: (6aR,9R)-N,N-diethyl-7-methyl-4-(4-(4,4,5,5-tetraethyl-1,3,2-dioxaborolan-2-yl)benzoyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Note: The shape and color of the pellets may vary externally.
The advantages of choosing us:
Laboratory-tested quality
All products containing 1BP-LSD are regularly tested. Samples from each new batch are sent to an external certified laboratory in Germany, where they are analyzed by mass spectrometry after dissolution in acetonitrile.
The following are confirmed:
- unambiguous identity of 1BP-LSD
- documented purity (97%)
- uniform distribution of active ingredient per unit
Analytics:
Quality control using HPLC / LC-MS / NMR
Typical Research Approaches:
- standardized comparative series
2. quantitative active ingredient analyses
3. methodological basic studies
4. reproducible test and reference models
All information is for scientific classification only and does not constitute a recommendation for use.
Long-lasting & many options
For maximum stability and durability, we recommend:
- store in a cool (< 20 °C) and dry place
- store away from light
- use the original packaging
Under proper conditions, storage for several years is possible.
- Clearly structured dosage levels: Micro and macrodosing units in a balanced ratio – ideal for standardized studies.
- Uniform reference substance: All units are based on 1BP-LSD, minimizing substance and batch variations.
- Proven dosage forms: Pellets and blotters enable reproducible test units with clear separation of dosage ranges.
Shipping & Discretion
Shipping is discreet and neutral via DHL from Germany.
- Shipping within 2 business days after receipt of payment
- unobtrusive packaging without content labeling
- free shipping from 69 €
- reliable & anonymous
Sender and manufacturer information:
Awakening GmbH
Fidicinstrasse 44
DE-10965 Berlin
+49 (0) 178 5493 709
mail@psychedelika.club
General questions:
If you have general questions about our products, please visit our FAQ page or Wikipedia.
What is 1BP-LSD?
As an LSD derivative, 1BP-LSD belongs to the group of ergoline compounds, which are the subject of scientific research in the field of perception and consciousness models.
Due to its synthetically precisely defined composition, 1BP-LSD is excellently suited for experimental setups based on reproducible and measurable experimental conditions.
That is why it is not prohibited:
According to the current version of the 6th NpSG Amendment Ordinance, 1BP-LSD does not appear to fall under the definition of Δ⁹,¹⁰-ergolines.
While the regulation includes several lysergamides substituted at position 1, it restricts the permissible substituents to an explicitly defined catalog.
Since the residue used in 1BP-LSD contains boron, which is not mentioned in this list, the compound does not meet the legal criteria from a purely formal perspective.
4)
4)
4)